Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Other Non-Current Liabilities (2022 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $759000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 73.17% to $759000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $759000.0 through Dec 2025, down 73.17% year-over-year, with the annual reading at $759000.0 for FY2025, 73.17% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $759000.0 at Werewolf Therapeutics, down from $2.6 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $2.8 million in Q2 2024, with the low at $191000.0 in Q2 2022.
  • Average Other Non-Current Liabilities over 3 years is $1.8 million, with a median of $2.6 million recorded in 2025.
  • Peak annual rise in Other Non-Current Liabilities hit 4.42% in 2025, while the deepest fall reached 73.17% in 2025.
  • Over 3 years, Other Non-Current Liabilities stood at $191000.0 in 2022, then soared by 1381.15% to $2.8 million in 2024, then crashed by 73.17% to $759000.0 in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $759000.0, $2.6 million, and $2.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.